Skip to content

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

Scientists at Stanford have created a new PET scan-compatible tracing agent that tracks immune cells poised to attack cancer, offering a new way to predict the success of certain therapies.

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

Published on

Current imaging technologies like MRI, CT scans and ultrasound provide valuable views inside the body, but each has drawbacks. MRIs require patients to remain still …

Published on

Will artificial intelligence (AI) replace radiologists? During a session on AI and imaging yesterday at the Big Data in Biomedicine conference, panelists preempted this question (which …

MRI is a powerful, non-invasive diagnostic tool widely used to investigate anatomical structures and functions in the body. Though generally considered to be safe, several studies …

Published on